PLASMINOGEN ACTIVATORS IN OVARIAN TUMOURS
- 1 July 1975
- journal article
- Published by Wiley in Acta Pathologica Microbiologica Scandinavica Section A Pathology
- Vol. 83A (2) , 193-198
- https://doi.org/10.1111/j.1699-0463.1975.tb01374.x
Abstract
Ovarian tumours obtained at laparotomy were histochemically examined for their local fibrinolytic activity, and simultaneous fibrin/fibrinogen degradation products (FDP) were determined in the serum. The fibrinolytic activity was confined mainly to vessels of both malignant and benign tumours. A very close correlation was demonstrated between the fibrinolytic activity and the vascularity of the sections. FDP were found in the serum in 13 of 14 patients with malignant tumours, but in none with benign tumours. The difference in occurrence of FDP in patients with malignant and benign tumours might be due to the invasive growth of the former with the entrance of thromboplastic substances, fibrinolytic activators or locally formed FDP into the bloodstream.Keywords
This publication has 13 references indexed in Scilit:
- Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumorsCancer, 1975
- Chronic Intravascular Coagulation in Metastatic Prostate CancerArchives of Surgery, 1973
- F.D.P.The Lancet, 1972
- Fibrin Degradation Products and Ovarian TumoursBMJ, 1971
- CLINICAL EXPERIENCE WITH DETERMINATION OF FIBRINOGEN DEGRADATION PRODUCTSActa Medica Scandinavica, 1971
- Localization of fibrinolytic activity in uterine cancerAmerican Journal of Obstetrics and Gynecology, 1969
- Quantitative Estimation of Split Products of Fibrinogen in Human Serum, Relation to Diagnosis and TreatmentBlood, 1966
- The histological localisation of fibrinolysin activatorThe Journal of Pathology and Bacteriology, 1959
- Coagulative properties of cancersIrish Journal of Medical Science, 1958
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952